Related references
Note: Only part of the references are listed.Tuberculosis in times of COVID-19
Alexandra Jaye Zimmer et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2022)
Impact of socio-economic factors on Tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study
Jasper Nidoi et al.
BMC PUBLIC HEALTH (2021)
Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach
Win Min Han et al.
PLOS ONE (2021)
Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial
Jason J. Madan et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2020)
Cost-effectiveness of treating multidrug-resistant tuberculosis in treatment initiative centers and treatment follow-up centers in Ethiopia
Senait Alemayehu et al.
PLOS ONE (2020)
Catastrophic costs due to tuberculosis worsen treatment outcomes: a prospective cohort study in Indonesia
Ahmad Fuady et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2020)
Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda
Samuel Kasozi et al.
PLOS ONE (2020)
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew J. Nunn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia: A systematic review and meta-analysis
Abriham Zegeye et al.
PLOS ONE (2019)
MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care
Marian Loveday et al.
PLOS ONE (2018)
How affordable is TB care? Findings from a nationwide TB patient cost survey in Ghana
Debora Pedrazzoli et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2018)
Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa
Denise Evans et al.
BMC HEALTH SERVICES RESEARCH (2018)
Decentralized care for multidrug-resistant tuberculosis: a systematic review and meta-analysis
Jennifer Ho et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2017)
Assessment of Directly Observed Therapy (DOT) following tuberculosis regimen change in Addis Ababa, Ethiopia: a qualitative study
Daniel Fiseha et al.
BMC INFECTIOUS DISEASES (2015)
Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa
E. Sinanovic et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients
K. J. M. Aung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Defining Catastrophic Costs and Comparing Their Importance for Adverse Tuberculosis Outcome with Multi-Drug Resistance: A Prospective Cohort Study, Peru
Tom Wingfield et al.
PLOS MEDICINE (2014)
Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach
Ivor Langley et al.
LANCET GLOBAL HEALTH (2014)
Patient-centered care and adherence: Definitions and applications to improve outcomes
Janice H. Robinson et al.
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS (2008)